Latest news
Loading news…
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3 Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
T3 Pharmaceuticals was acquired by Boehringer Ingelheim in 2023 for $509.33M.
Total Funding
$38.91M
Funding Rounds
4
Last Funding
Acquisitions
0
Monthly Visits
Contacts
6
About T3 Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Basel, Basel-Stadt, Switzerland
T3 Pharmaceuticals Funding Rounds
4 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–4 of 4Show
Page 1 / 1
T3 Pharmaceuticals Key People
CSO and Co-founder
CEO and Co-founder
6
professional contacts at T3 Pharmaceuticals
Contact execs at T3 Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to T3 Pharmaceuticals
Loading news…
FAQs about T3 Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.